Cellebrite DI Ltd. — Regulatory Filings 2021

Oct 4, 2021

CORRESP 1 filename1.htm

Cellebrite DI Ltd.

94 Shlomo Shmelzer Road

Petah Tikva, Israel

October 4, 2021

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Technology

100 F Street, NE Washington, D.C. 20549

Attn:	Jan Woo
	Matthew Crispino
Re:	Cellebrite DI Ltd.
	Registration Statement on Form F-1
	Filed September 27, 2021, as amended
	File No. 333-259826

Dear Ms. Woo and Mr. Crispino:

Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Cellebrite DI Ltd. respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on October 6, 2021, or as soon thereafter as practicable.

Please call Colin Diamond of White & Case LLP at (212) 819-8754 to provide notice of the effectiveness of the Registration Statement.

[ Signature Page Follows ]

Field: Page; Sequence: 1

Field: /Page

Very truly yours,
Cellebrite DI Ltd.
By:	/s/ Yossi Carmil
Name: Title:	Yossi Carmil Chief Executive Officer

cc:
Colin Diamond, White & Case LLP

Field: Page; Sequence: 2; Options: Last

Field: /Page